TrialBlood2025

Prognostic value of premaintenance FDG PET/CT response in patients with newly diagnosed myeloma from the CASSIOPEIA trial.

Françoise Kraeber-Bodéré et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.